During the past decade, Regional Clinical Research, Inc. conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 35 clinical trials were completed, i.e. on average, 102.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 25 clinical trials were completed. i.e. 416.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Clinical Research, Inc." #1 sponsor was "Pfizer" with 12 trials, followed by "Takeda" with 4 trials sponsored, "Allergan" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Janssen Vaccines & Prevention B.V." with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Clinical Research, Inc." #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Norwich Clinical Research Associates Ltd." with 1 trials as a collaborator and "Novartis Vaccines" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Regional Clinical Research, Inc." are "Influenza" (9 trials), "Migraine" (4 trials), "Migraine, With or Without Aura" (4 trials), "Overactive Bladder" (3 trials) and "Lyme Borreliosis" (2 trials). Many other conditions were trialed in "Regional Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Regional Clinical Research, Inc." are "Drug" (31 trials), "Biological" (26 trials), "Device" (3 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Rimegepant" (3 trials), "Influenza virus vaccine (Fluviral)" (2 trials), "Naproxen" (2 trials) and "Placebo-matching Ubrogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Regional Clinical Research, Inc." are 56 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Regional Clinical Research, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Regional Clinical Research, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Clinical Research, Inc., 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".